Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Cell
|
| gptkbp:administered_by |
subcutaneously
intravenously |
| gptkbp:amended_by |
cytokine production
|
| gptkbp:can_be_combined_with |
radiation therapy
chemotherapy other immunotherapies |
| gptkbp:can_be_used_in |
melanoma treatment
multiple sclerosis treatment certain leukemias chronic hepatitis C treatment |
| gptkbp:community |
adaptive immunity
|
| gptkbp:enhances |
antigen presentation
antiviral activity T-cell response B-cell activity |
| gptkbp:has_impact_on |
modulating immune response
|
| gptkbp:has_method |
JAK-STAT signaling pathway
|
| gptkbp:has_role |
immune response
|
| gptkbp:has_type |
gptkb:IFN-alpha
gptkb:IFN-beta gptkb:IFN-gamma |
| https://www.w3.org/2000/01/rdf-schema#label |
IFN
|
| gptkbp:influence |
inflammatory response
|
| gptkbp:initiated_by |
gptkb:Cell
cell proliferation tumor growth viral replication dendritic cells immunosuppressive drugs NK cells viral protein synthesis |
| gptkbp:involved_in |
cell signaling
|
| gptkbp:is_involved_in |
autoimmune diseases
infectious diseases cancer progression chronic inflammation |
| gptkbp:is_regulated_by |
gene expression
|
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:is_targeted_at |
gptkb:monoclonal_antibody
small molecules |
| gptkbp:measures |
serum levels
|
| gptkbp:participated_in |
MHC class I expression
apoptosis in infected cells |
| gptkbp:produced_by |
gptkb:Cell
fibroblasts lymphocytes monocytes response to pathogens |
| gptkbp:side_effect |
gptkb:depression
fatigue autoimmune disorders flu-like symptoms |
| gptkbp:used_in |
cancer therapy
treatment of viral infections |
| gptkbp:bfsParent |
gptkb:Isfahan_International_Airport
|
| gptkbp:bfsLayer |
6
|